epratuzumab

Ligand id: 8088

Name: epratuzumab

Immunopharmacology Comments
Epratuzumab was investigated for antiinflammatory actions in SLE, but was found not to be effective following Phase 3 trial evaluation [3,6].
Immunopharmacology Disease
Disease X-Refs Comment References
Systemic lupus erythematosus Disease Ontology: DOID:9074
OMIM: 152700
Orphanet: ORPHA536
Epratuzumab is being investigated for antiinflammatory actions in SLE.